FCM
IDYA icon

Fieldview Capital Management’s IDEAYA Biosciences IDYA Stock Holding History

Fieldview Capital Management’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,040
Closed -$335K – 609
2026
Q1 		$335K Buy
+10,040
New +$337K 0.1% 358

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Fieldview Capital Management's IDYA Position: Q2 2026 in Review

Fieldview Capital Management sold out of IDEAYA Biosciences (IDYA) in Q2 2026, closing a stake of 10,040 shares — an estimated $335K sold.

Fieldview Capital Management first reported a position in IDYA in Q1 2026 and held it in 1 quarter. The position peaked at $335K in Q1 2026. 284 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • Fieldview Capital Management reported no remaining IDEAYA Biosciences position as of Q2 2026 after selling out during the quarter.
  • Fieldview Capital Management sold 10,040 IDEAYA Biosciences shares in Q2 2026, an estimated $335K.
  • Fieldview Capital Management first reported a position in IDEAYA Biosciences in Q1 2026 and held it in 1 quarter.
  • Fieldview Capital Management's IDEAYA Biosciences position peaked at $335K in Q1 2026.
  • 284 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Fieldview Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.